Bladder Cancer Grants and Research Awards

Listed below are Bladder Cancer Advocacy Network (BCAN) research grants along with descriptions of each, deadlines, eligibility and more. For more information about these grants, please contact grants@bcan.org. Please visit our Grants and Research page for more information about each award.

	Translational Clinical Trial Award	Research Innovation Award	Career Development Award	Young Investigator Award (YIA) & Young Investigator Award for Patient-Centered Clinical Research (YIA-PCC)	John Quale Travel Fellowship
Application Deadline	LOI: October 18, 2022 Invited Application: January 10, 2023	LOI: January 2023 Invited Application: April 2023	October 18, 2022	February 2023	March 2023
Purpose	Supports early-phase patient-oriented translational research that transforms bladder cancerf care Projects should address methods to reduce the burden of care or overtreatment for bladder cancer patients and have the potential to generate the evidence needed to advance clinical practice, guidelines, or standard of care	Supports exceptionally novel and creative projects with great potential to produce breakthroughs in our understanding of bladder cancer Projects must be high-risk, high-reward vs. incremental in nature	Supports junior investigators who have received their initial faculty appointment to establish an independent bladder cancer research program and career path	Supports the development of research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer YIA-PCC: Supports patient-oriented clinical bladder cancer research	Supports early career investigators interested in bladder cancer research to attend the annual Bladder Cancer Think Tank Meeting. The travel fellowship is intended to defray travel-related costs for attending the meeting
Research Focus	Must address methods to reduce the burden of care or overtreatment for bladder cancer patients throughout the continuum of patient care Preference will be given to innovative clinical trials or translational research from ongoing or completed trials Proposals that do not include a clinical trial must justify how the study will lead to a clinical trial as an immediate next step, or allow for translation of results into clinical practice	Must have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma and include innovative approaches and new ideas (e.g., novel theoretical concepts, methodologies, instrumentation, interventions, etc.) Basic, translational, clinical, or epidemiologic research is acceptable	Must have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma and must demonstrate the likelihood of translating new concepts into clinical practice Translational, clinical, or epidemiological research is acceptable	Must be specific to bladder cancer and/or upper tract urothelial carcinoma YIA: Basic, translational, clinical, epidemiologic, bioengineering or any other field of research is acceptable YIA-PCC: Must be patient-oriented clinical bladder cancer research (e.g., studies of shared decision making, access to care, quality of care, quality of life, health disparities, comparative effectiveness research, patient-centered outcomes research, and survivorship)	The travel fellowship seeks to engage early career investigators with interests related to bladder cancer, including basic scientists, urologists, oncologists, and pathologists
Eligibility	Full-time, independent investigators. Study teams must be composed of at least two investigators Investigators with relevant expertise outside of bladder cancer seeking to apply approaches to bladder cancer are encouraged	Full-time, independent investigators Investigators with relevant expertise outside of bladder cancer seeking to apply approaches to bladder cancer are encouraged	Applicant must be within the initial 7 years of their first full-time faculty appointment Applicant may not hold the title of Associate or Full Professor Applicant may not have previously secured major independent research funding (NIH R01 or equivalent)	Applicant must be within 6 years of completion of a professional degree or clinical training Applicant may not hold the title of Associate Professor or higher	Applicants with a MD or PhD at the post-graduate, pre-faculty level who have not yet started a faculty appointment at the time of submission Prior JQTF winners are not eligible
Required Degree	Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research	Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research	Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research	YIA: Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research. PCC: MD, DO, PhD, MD-PhD, MPH, MS, DNP, DScPAS or equivalent.	MD in the final year of residency or a fellowship program; PhD postdoctoral fellows
Award Period	Up to 3 years	2 years	3 years	1 year	Bladder Cancer Think Tank Meeting 2022: August 3-5^th
Total Funding Indirect Costs	Studies proposing clinical trials: Up to $3 million All other studies: Up to $1 million A maximum of 10% of total costs may be used for indirect costs	$300,000 ($150,000 per year) A maximum of 10% of total direct costs may be used for indirect costs	$250,000 over 3 years Up to 7% per year may be applied to indirect costs	$75,000 Not allowable	$2,000 N/A
Mentored Award?	No	No	No	Applicant must have a mentor within or approved by the sponsoring institution	N/A

Bladder Cancer Grants and Research Awards

Read Our Stories

Read Jim Zito – “Never give up hope!”

Read Megan’s Bladder Cancer Story

Read Ben Manages an Unexpected Diagnosis

Read Sharing Stories to Advance Research – Camille’s Story